David Andersen

• Represented music companies in structuring, investing in and buying and selling new record labels and other music assets
• Represented a media and entertainment company in the acquisition of one of the world's most iconic kids-focused entertainment brands and in a subsequent joint venture with a prominent multinational corporation to further develop such brand
• Represented a leading entertainment company in the $100 million acquisition of an entertainment marketing company
• Represented a biopharmaceutical company in a $750 million cross-border sale of select assets and in a subsequent $420 million public tender offer structured to return capital to domestic and international shareholders
• Represented a California-based IPA in the $545 million sale of its healthcare-related assets to a publicly traded health management company via a series of related preferred stock, common stock and lending transactions
• Represented a global consumer electronics company in its $900 million sale to an international consumer brands and manufacturing company
• Represented a transplantation laboratory in its sale to a national laboratory and diagnostics corporation
• Represented a dental HMO in its sale to a leading national HMO
• Represented a private equity buyer in the acquisition of an international franchising company with multiple restaurant brands, and subsequently represented the company in its sale to another restaurant franchisor and operator, aggregating to approximately $500 million
• Represented a regional chain of skilled nursing facilities in its acquisition of a company providing physical therapy services
• Represented buyer in the acquisition of a leading international home networking  brand
• Represented significant shareholder in the $3 billion sale of audio equipment and music streaming businesses
• Represented a manufacturing company in a $500 million cross-border restructuring and business combination, and in its subsequent sale to a global consumer packaging company
• Represented a medical device company in its sale to a leading international provider of renal care products and services
• Represented the issuer in a $100 million venture capital investment and recapitalization transaction
• Represented a fast-casual restaurant company in multiple rounds of private equity financing, totaling approximately $50 million
• Represented a medical group in a restructuring and spin-off transaction with a hospital chain
• Represented a party to a merger of publicly traded healthcare companies and with respect to the related S-4 registration statement
• Represented the issuers and venture capital firms in numerous private placement financings in industries such as software, financial technology, digital health, gaming, social media and biotechnology
• Numerous acquisitions and sales of public and private companies in industries such as software, hardware, telecom, financial technology, IT services, healthcare services, biotechnology and entertainment and new media
• Served as issuer's counsel in Rule 144A offerings, secondary public offerings, and the initial public offering of a technology company

*These matters occurred prior to joining Barnes & Thornburg.